2月21日 - ** 基因检测公司NateraNTRA.O股价下跌4.2%，报160.63美元；医疗诊断公司Guardant HealthGH.O股价下跌10.5%，报42.40美元。
** Guardant Health公司在加州联邦法院起诉竞争对手Natera公司，称其窃取了与癌症检测血液测试有关的商业机密。
** 在周四提交的诉讼中 (link)，Guardant称，被Natera挖走的科学家向该公司转移了数千份机密文件，以开发竞争性测试产品。
** NTRA否认这些指控，称其 "毫无根据"，并表示将为自己的指控辩护
** GH 正寻求法院下令阻止科学家共享其机密，并寻求金钱赔偿
** Guardant 的律师和发言人没有立即回应置评请求
** 2024 年，嘉禾集团的业绩增长了 15.3%，NTRA 的业绩增长了一倍多。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.